Got News to Share? Send 2 FREE Releases ↓
All News Topics | Events By Topic | By Country | By State | By Date

Partnership Valuation in Pharma

Submit News
Date: 01-Dec-14 to 02-Dec-14
Location: Mövenpick Hotel Berlin / Berlin / Germany
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

• Deepen your understanding of the complex aspects in valuation of products, companies and technology platforms
• Listen to best practice examples from pharmaceutical and biotech companies, their strategies and tools to master challenges like pricing and reimbursement
• Hear about the different valuation models of early stage products versus late stage products


Companies and institutes invited to speak:
• AstraZeneca AB
• Merck & Co.
• Bayer Pharma AG
• Novartis AG
• Hoffmann-La Roche Ltd.
• Medivir AB
• Avance
• Gilead Sciences, Inc.
• Boehringer Ingelheim GmbH
• Sanofi S.A.
• Bayer Schering Pharma AG
• Polyphor Ltd.
• Grünenthal GmbH
• Novo Nordisk A/S
• Merck Serono
• Amgen, Inc.
• Pfizer, Inc.
• Astellas Pharma, Inc.
• MorphoSys AG
• UCB Pharma Ltd.

Exhibitors

Dr. Kay Brickmann - Business Development Director Scientific Partnering & Alliances - AstraZeneca AB - Sweden, Morten Faester - Director Business Development - Medivir AB - Sweden, Ralph Villiger - Managing Director - Avance - Switzerland

Go to event website